Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,339 public trials 1,980 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Recruiting

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

NCT06686394

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of Colorado Anschutz Medical Campus ( Site 0057) Aurora, Colorado, United States
  • Dana-Farber Cancer Institute ( Site 0050) Boston, Massachusetts, United States
  • Rutgers Cancer Institute of New Jersey ( Site 0052) New Brunswick, New Jersey, United States
  • Prisma Health - Upstate (ITOR)_Edenfield ( Site 0053) Greenville, South Carolina, United States
View all 18 locations
View Trial Details
Recruiting

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

NCT07459673

Conditions
Breast Cancer, Breast Cancer Stage IV, Breast Diseases, +6 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering at Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns

NCT06551220

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute, Harvard Medical School Boston, Massachusetts, United States
  • Fujian Cancer Hospital, Fujian Medical University Fuzhou, Fujian, China
  • The 10th Affiliated Hospital of Southern Medical University Dongguan, Guangdong, China
View all 26 locations
View Trial Details
Recruiting

A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.

NCT07593820

Conditions
Breast Diseases, Breast Neoplasms, Digestive System Diseases, +12 more
Locations
  • Hospital Del Mar Barcelona, Catalonia, Spain
  • Hospital Universitari Vall D Hebron Barcelona, Catalonia, Spain
View Trial Details
Recruiting

Saci Nivo Rela for TNBC

NCT06963905

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Triple-negative Breast Cancer, +5 more
Locations
  • Yale University New Haven, Connecticut, United States
View Trial Details

Related conditions